openPR Logo
Press release

ARTIFICIAL PANCREAS MARKET - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016-2024

02-28-2017 05:09 PM CET | Health & Medicine

Press release from: ARTIFICIAL PANCREAS MARKET

ARTIFICIAL PANCREAS MARKET - GLOBAL INDUSTRY INSIGHTS, TRENDS,

Artificial pancreas is a disruptive technology that is expected to revolutionize the diabetes market in near future especially for type 1 diabetes treatment. Type 1 diabetes, characterized by inadequate insulin production, requires daily administration of insulin to regulate the amount of glucose in the body. Thus, patients suffering from type 1 diabetes need to be regularly monitor their blood glucose levels and administer insulin accordingly. According to the World Health Organization (WHO), number of diabetes patients worldwide has increased from 108 million in 1980 to 422 million in 2014. According to Juvenile Diabetes Research Foundation (JDRF), there were around 1.5 million type 1 diabetics worldwide in 2015. There are no commercially available treatment option for type 1 diabetes. Therefore, organizations such as JDRF and OpenAPS are focusing only on developing effective and compliant therapies for type 1 diabetes. Artificial pancreas market outlook is optimistic for early entrants.

Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/79

Medtronic’s MiniMed 670G – The First of its Kind in Artificial Pancreas Market Outlook

Medtronic entered the artificial pancreas market with introduction of MiniMed. MiniMed 670G—the first of its kind artificial pancreas for treatment of diabetes 1—received FDA approval in September 2016. The device would be made available in 2017. MiniMed 670G combines an automated glucose monitor and an insulin pump. The FDA has granted approval for this device to be used in patients aged 14 years and above. Once additional real-life tests are successfully carried out by the company, the product would be accessible to the target user group, mainly the pediatric population.

MiniMed 670G is a hybrid closed-loop system that automates the cumbersome process of monitoring and adjusting glucose and insulin levels in type 1 diabetes patients. Patients can monitor health through a device like a smartphone. This artificial pancreas would help patients sleep well at night and wake-up with a healthy glucose levels. Moreover, Medtronic’s MiniMed 670G artificial pancreas would improve therapy adherence and allow patients to live life unlike previously where there was a need for regular intervention. Various regional players are expected emerge in the artificial pancreas market in near future in order to capitalize on lucrative growth opportunities.

However, emergence of other disruptive technology could somewhat affect the overall growth of artificial pancreas market revenue. For instance, automated insulin delivery device is a prospective alternative to artificial pancreas. OpenAPS—a do-it-yourself (DIY) automated insulin delivery system—is an open source design that can be used by anyone to connect their CGM and insulin pump to make it an artificial pancreas. The device was developed in 2013 by Ben West, Dana Lewis, and Scott Leibrand.

North America and Europe to dominate the Artificial Pancreas Market Size

According to the Center for Disease Control and Prevention (CDC), there were 29.1 million diabetic patients in the U.S. in 2015, of which 8.1 million are undiagnosed. Type 1 diabetes accounts for around 5% of the total diagnosed diabetes cases in adults in the U.S. Type 1 diabetes is common among Scandinavian population and in Sardinia and Kuwait and less common in Asia and Latin America. Developed regions are expected to dominate the artificial pancreas market size, owing to early adopters of disruptive technology. Success achieved in these markets influences companies to enter into emerging markets, where the regulations, distribution and purchase/treatment patterns vary widely.

Browse Global Strategic Business Report : https://www.coherentmarketinsights.com/ongoing-insight/artificial-pancreas-market-79

Conclusion

Medtronic’s MiniMed 670G artificial pancreas only needs to be calibrated by the patient, while the rest is taken care of by the automated device. Adoption would be a little slow, especially in developing countries, considering the high price of the device. However, given the long-term gains from the device, adoption is expected to increase over time. According to the CDC, the annual healthcare burden due to diabetes to the U.S. government was US$ 176 billion in 2012. Governments and insurance providers are pushing pharmaceutical and medical device companies to reduce medicine and device costs. This is expected to have a significant impact on the pricing of the artificial pancreas. There is high demand for effective treatment of diabetes. As such, addressable market is expected to generate high return on investment (ROI) for artificial pancreas market players.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ARTIFICIAL PANCREAS MARKET - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016-2024 here

News-ID: 451736 • Views: 378

More Releases from ARTIFICIAL PANCREAS MARKET

Artificial Pancreas Market, Company Analysis and Forecast to 2024
Artificial pancreas is a disruptive technology that is expected to revolutionize the diabetes market in near future especially for type 1 diabetes treatment. Type 1 diabetes, characterized by inadequate insulin production, requires daily administration of insulin to regulate the amount of glucose in the body. Thus, patients suffering from type 1 diabetes need to be regularly monitor their blood glucose levels and administer insulin accordingly. According to the World Health
Artificial Pancreas Market, Company Analysis and Forecast to 2024
Artificial pancreas is a disruptive technology that is expected to revolutionize the diabetes market in near future especially for type 1 diabetes treatment. Type 1 diabetes, characterized by inadequate insulin production, requires daily administration of insulin to regulate the amount of glucose in the body. Thus, patients suffering from type 1 diabetes need to be regularly monitor their blood glucose levels and administer insulin accordingly. According to the World Health
Artificial Pancreas Market -Trends, Outlook, and Opportunity Analysis, 2016-2024
Artificial pancreas is a disruptive technology that is expected to revolutionize the diabetes market in near future especially for type 1 diabetes treatment. Type 1 diabetes, characterized by inadequate insulin production, requires daily administration of insulin to regulate the amount of glucose in the body. Thus, patients suffering from type 1 diabetes need to be regularly monitor their blood glucose levels and administer insulin accordingly. According to the World Health
Artificial Pancreas Market - Global Industry Insights, Trends, Outlook, and Oppo …
Artificial pancreas is a disruptive technology that is expected to revolutionize the diabetes market in near future especially for type 1 diabetes treatment. Type 1 diabetes, characterized by inadequate insulin production, requires daily administration of insulin to regulate the amount of glucose in the body. Thus, patients suffering from type 1 diabetes need to be regularly monitor their blood glucose levels and administer insulin accordingly. According to the World Health

All 5 Releases


More Releases for MiniMed

Global mHealth Applications Market 2019 with Top key Manufacturer (Allscripts, A …
mHealth is an abbreviation for mobile health, a term used for the practice of medicine and public health supported by mobile devices. The term is most commonly used in reference to using mobile communication devices, such as mobile phones, tablet computers and PDAs, and wearable devices such as smart watches, for health services, information, and data collection. The mHealth field has emerged as a sub-segment of eHealth, the use of
MHealth Applications Market 2019 Global Analysis By Key Players – Allscripts, …
mHealth Applications Market 2019 Wiseguyreports.Com adds “mHealth Applications Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Report Details: This report provides in depth study of “mHealth Applications Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The mHealth Applications Market report also provides an in-depth survey of key players in the market which is based on the various objectives
Global mHealth Applications Market 2019:2025 - Agamatrix , Apple , Honeywell , M …
The mHealth Applications Global market 2019-2025 from QY research gives basic data to advertisers, managers, analysts, business consultants, senior management and different key individuals that with the critical information need to assess global mHealth Applications market. This information is optimistic for the commercials, residential & industrial buyers, governments and other shareholders to present their product-centric tactics in proportion to the projected as well as existing trends in the mHealth
mHealth Applications Market Growth Analysis By Top Leading Players -Allscripts, …
2018-2023 Global mHealth Applications Market Report Status and Outlook mHealth is an abbreviation for mobile health, a term used for the practice of medicine and public health supported by mobile devices. The term is most commonly used in reference to using mobile communication devices, such as mobile phones, tablet computers and PDAs, and wearable devices such as smart watches, for health services, information, and data collection. The mHealth field has emerged
Global mHealth Applications Market Forecast to 2025 : Allscripts, Agamatrix, App …
ResearchMoz presents professional and in-depth study of "Global mHealth Applications Market Size, Status and Forecast 2018-2025" This report focuses on the global mHealth Applications status, future forecast, growth opportunity, key market and key players. The study objectives are to present the mHealth Applications development in United States, Europe and China. mHealth is an abbreviation for mobile health, a term used for the practice of medicine and public health supported by mobile devices.
mHealth Applications Market Trends and Industry Overview Report 2018 - Allscrip …
mHealth Applications Market According to a new market research report titled, ‘mHealth Applications Market’, added on Reports Monitor. The report has been processed on the basis of a comprehensive analysis with inputs from industry experts. The report presents the market scenario and its potential growth prospects during the forecast period. In addition, the report consists of the list of the leading players operating in the market. Request a Sample Report @ https://www.reportsmonitor.com/request_sample/85062 mHealth is